Computer Aided Detection Market
Computer Aided Detection Market Study by Mammography, MRI, CT, and Tomosynthesis from 2023 to 2033
Analysis of Computer Aided Detection Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Computer Aided Detection Market Outlook (2023 to 2033)
The global computer aided detection market is forecasted to surge ahead at a CAGR of 10% from 2023 to 2033. The market is valued at US$ 1.5 billion in 2023 and is thus anticipated to reach US$ 3.9 billion by 2033-end.
Computer-assisted mammograms improve the quality of breast cancer diagnostics because they can be enhanced, zoomed, or otherwise altered for better analysis. The goal of computer aided detection is to decrease false-negative results and observational errors. It aids in the diagnosis and early detection of cancer, neurological conditions, and cardiovascular issues using imaging modalities.
Computer aided assistance in medical sciences has existed for a long time. Over the last two decades, doctors, researchers, and practitioners have been using medical imaging devices that are integrated with computer aided detection or computer aided diagnosis.
Computer aided detection is used to increase the sensitivity of diagnostic imaging in case of medical investigation and differential diagnostics. Computer aided detections enable the timely detection of debilitating diseases such as cancer. This has motivated patients to opt for random tests and checkups. On the back of these trends, the global computer aided detection market is anticipated to register imminent growth opportunities over the coming years.
The performance and efficiency of computer-aided detection systems have also been improved by advanced digital imaging techniques, opening up the lucrative potential for market participants during the projection period. Market growth rate will also be facilitated by expenditures in research and development of 3D imaging. Market expansion is expected to boost by increased disposable income and healthcare spending in emerging economies throughout the forecast period.
Market growth is further aided by rising awareness, rising investments, population growth, changing lifestyles, rising adoption of inorganic growth tactics, and government support for healthcare infrastructure. Medical tourism and the gradually rising need for health insurance are two additional important aspects anticipated to support market expansion.
The availability of health insurance plans is contributing to the expansion of the computer aided detection market. The availability of health insurance policies is crucial since it allows for the greatest medical care to be obtained without financial pressure.
Health insurance policies protect against the high medical expenditures associated with computer-aided detection and pay for things such as hospitalization bills, daycare procedures, and other fees. Health insurance plans allow you to concentrate on your quick recovery rather than fretting about the expensive charges of computer aided detection.
Report Attributes |
Details |
|
Computer Aided Detection Market Size (2023) |
US$ 1.5 Billion |
|
Projected Market Value (2033) |
US$ 3.9 Billion |
|
Global Market Growth Rate (2023 to 2033) |
10% CAGR |
|
Market Share of Mammography |
50% |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Why are Computer Aided Detection Systems High in Demand?
“Increasing Need for Error-free Detection of Chronic Diseases in Their Early Stages”
The global computer aided detection market is expanding due to the rising prevalence of various chronic diseases such as stroke, various malignancies, cardiovascular disorders, and neurological dysfunctions. Additionally, the enhanced government initiatives to promote cancer awareness and treatment are anticipated to drive the global demand for computer aided detection systems.
Market expansion is expected to be fostered by several patients choosing diagnostic imaging methods. The market is anticipated to grow as a result of the growing usage of computer aided detection systems in clinical research activities, as well as growing awareness among healthcare professionals of their benefits, including their ability to accurately detect chronic diseases in their early stages and lower mortality rates from cancer, cardiovascular, and neurological diseases. Increasing awareness of successful cancer treatments among patients is driving market value.
Early cancer detection is made possible by computer aided detection tools, which aid in the treatment of many cancer patients. Additionally, a major driver propelling the expansion of the market for computer aided detection is the increase in computer-aided tests being performed globally as a result of many patients seeking routine checkups.
Rapid innovations in the healthcare industry are fueling market expansion. Artificial intelligence (AI) development and increased sensitivity are two recent advancements that are expected to support market growth. Medical imaging equipment combined with computer aided detection is used by medical researchers and doctors. The demand for computational support is growing as a result of the need for error-free detection.
Physicians may more quickly identify abnormal tissue, serving as the first line of defense in the fight against cancer with the help of computer aided detection (CAD) technology. Thanks to advances in computer technology, CAD, which has been around for almost ten years, has emerged as an important cancer detection tool.
Computer aided detection system providers have expanded the technology's applicability to the chest, lungs, and colon. Computer aided detection can completely transform breast imaging technologies, displacing current visualization methods. Computer aided detection will be used to support more of the diagnostic interpretation process.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Can Restrict Global Adoption of Computer Aided Detection Tools?
“High Cost of Computer Aided Detection Systems and Lack of Skilled Professionals”
Development of the market for computer aided detection is also expected to be hampered by a lack of trained professionals to operate computer aided detection systems. A potential risk of failure in identifying abnormalities, unfavorable reimbursement policies, and low awareness in rural areas are expected to obstruct market growth.
High costs associated with computer aided detection tools are projected to challenge market expansion over the coming years, according to pricing trends. People typically choose conventional techniques of diagnosis because the majority of medical insurance companies do not provide coverage for operations using computer-aided detection.
How Can Emerging Market Players Increase their Revenue Share?
“New Companies Focused on R&D to Introduce Novel Early Cancer Detection Systems’”
New entrants are focusing on R&D to offer novel early cancer detection systems using AI and the most advanced medical imaging technology. Start-ups are enhancing product standards and concentrating on the local supply of computer aided detection devices to make a mark in this industry.
- VoxelCloud, a start-up based in the United States, offers automated medical image analysis services and diagnosis support based on cloud computing and artificial intelligence technologies to healthcare practices and practitioners. VoxelCloud creates computer-aided detection systems for identifying and diagnosing a range of illnesses, from the eye and cardiovascular conditions to lung and cardiovascular conditions. Through deep learning and related AI techniques, VoxelCloud's unique algorithms provide precise, easily accessible, and customized medical image analysis. Lung cancer, retinal conditions, and coronary heart disease are all covered by the company's product offerings.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Region Should Computer Aided Detection System Providers Invest In?
“New Developments in Advanced Breast Cancer Imaging in North America”
North America accounts for 40% share of the global market owing to increasing incidences of breast cancer.
New developments in advanced breast cancer imaging techniques and an increase in awareness about early breast cancer screening are also anticipated to drive the North American market forward. The market for computer aided detection is expanding in North America due to the availability of advanced diagnostic equipment in most hospitals and a well-established healthcare system.
Country-wise Insights
Why is the United States a Major Market for Computer Aided Detection?
“Increase in Computer-aided Cancer Detection Centers”
- According to the American Cancer Society, 1.9 million new cases of cancer were diagnosed in the United States in 2022, and more than 600,000 of those individuals passed away.
The high rate of cancer-related mortality is an important reason driving the demand for computer-aided cancer detection and diagnosis.
A rise in businesses producing computer aided detection devices, the growing healthcare expenditure, and the increased adoption of CAD for cancer diagnosis are anticipated to fuel market expansion over the coming years. An increase in computer-aided cancer detection centers and the installation of innovative computer-aided digital devices are driving market growth in the country.
What is the Demand Outlook for Computer Aided Detection Systems in Japan?
“Government Initiatives to Raise Cancer Awareness”
Japan is anticipated to be the most attractive market for computer aided detection technologies. A large patient pool, owing to a huge population base and subsequent incidences of diseases shall propel market growth.
Moreover, affordable investment costs have motivated key manufacturers to increase their scale of operations, thus boosting the computer aided detection market. Government initiatives and campaigns to raise cancer awareness, the surging need for routine checkups, and rising investments in R&D activities are driving market growth.
Which European Country is Likely to Be a Prominent Marketplace?
“Availability of Efficient Computer-aided Diagnostic Facilities in Germany”
Major factors influencing market revenue growth in Germany include the availability of efficient computer-aided diagnostic facilities and an increase in medical tourism. The availability of modern computer aided detection tools at a very reasonable cost is another reason for boosting market value in the country.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Why is Demand for Mammography Gaining Ground?
“Growing Prevalence of Breast Cancer Driving Demand for Mammography”
By imaging modality, the market is segmented into mammography, MRI, CT, tomosynthesis, and others. Mammography accounts for 50% share of the global market owing to rising incidences of breast cancer among women. Mammography is majorly performed for two purposes, including diagnostic and simple screening for genetic traits of breast cancer.
The emergence of advanced mammography systems with advanced features, rapid adoption of computer aided diagnosis systems in multispecialty hospitals, and growing awareness of early diagnosis and treatment of breast cancer are the major factors driving demand for mammography procedures. Additionally, when compared to standard film mammograms, computer-assisted digital mammograms considerably reduce the amount of radiation that cancer patients are exposed to, protecting them from potentially toxic radiation side effects.
Which Application Accounts for High Revenue Generation?
“Increasing Awareness about Early Breast Cancer Detection Driving Demand for Computer Aided Detection Systems in Oncology”
Based on the application, the market is divided into oncology, cardiovascular & neurological indications, and others. The adoption of computer aided detection systems in oncology is increasing due to rising cancer prevalence, increased public knowledge of different cancer types, the significance of early-stage cancer detection, and the introduction of technologically advanced hardware and software.
The rise in regular medical checkups and government & non-government programs to raise awareness of cancer prevention are boosting the demand for computer aided detection systems in oncology. The identification of breast cancer via mammography is improved with the use of computer aided detection in oncology. Computer aided detection is a helpful tool for the enhanced detection of breast cancer regardless of the size of the tumour and is used as a cue for the radiologist to identify potential areas of abnormality on the mammogram.
Competitive Landscape
Leading companies are focusing on quality control & supply chain management and launching highly effective computer aided detection systems following safety regulations to lower the environmental impact. The market is likely to be driven by government initiatives to broaden the applications of CAD with other modalities and key player tactics to introduce novel computer aided detection tools.
For instance :
- GE Healthcare provides diagnostic imaging solutions, healthcare IT solutions, radiography, and fluoroscopy. Its mammography systems include SenoClaire, SenoBright CESM, and Pristina Serena 3D devices.
- In 2019, Paragon Biosciences LLC founded Qlarity Imaging LLC to create QuantX, a computer-aided detection system for breast cancer.
Key Segments of Computer Aided Detection Industry Research
-
By Imaging Modality :
- Mammography
- MRI
- CT
- Tomosynthesis
- Others
-
By Application :
- Oncology
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Bone Cancer
- Cardiovascular & Neurological Indications
- Others
- Oncology
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2027 3.2. Global Market: Market Snapshot 4. Market Overview 4.1. Global Market Overview 4.2. Global Market Key Industry Developments 5. Market Dynamics 5.1. Drivers and Restraints Snapshot Analysis 5.2. Drivers 5.3. Restraints 5.4. Opportunities 5.5. Key Trends 5.6. Global Market Revenue Projections (US$ Mn), 2023–2033 5.7. Regulatory Framework 5.8. Heat Map Analysis - Company 6. Global Market Analysis, by Application 6.1. Introduction 6.2. Key Insights 6.3. Global Market Size and Forecast, by Application 6.3.1. Oncology 6.3.1.1. Breast Cancer 6.3.1.2. Lung Cancer 6.3.1.3. Colorectal Cancer 6.3.1.4. Prostate Cancer 6.3.1.5. Liver Cancer 6.3.1.6. Bone Cancer 6.3.1.7. Others 6.3.2. Cardiovascular and Neurological Indications 6.4. Global Market Analysis, by Application 6.5. Global Market Attractiveness Analysis, by Application 7. Global Market Analysis, by Imaging Modality 7.1. Introduction 7.2. Key Insights 7.3. Global Market Size and Forecast, by Imaging Modality 7.3.1. Mammography 7.3.2. MRI 7.3.3. Ultrasound Imaging 7.3.4. Tomosynthesis 7.3.5. CT 7.3.6. Others 7.4. Global Market Analysis, by Imaging Modality 7.5. Global Market Attractiveness Analysis, by Imaging Modality 8. Global Market Analysis, by Region 8.1. Introduction 8.2. Key Insights 8.3. Global Market Size and Forecast , by Region, 2018–2027 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Latin America 8.3.5. Middle East & Africa 8.4. Global Market Analysis, by Region 8.5. Global Market Attractiveness Analysis, by Region 9. North America Market Analysis 9.1. North America Market Key Findings 9.2. North America Market Overview 9.3. North America Market Size and Forecast, by Application 9.3.1. Oncology 9.3.1.1. Breast Cancer 9.3.1.2. Lung Cancer 9.3.1.3. Colorectal Cancer 9.3.1.4. Prostate Cancer 9.3.1.5. Liver Cancer 9.3.1.6. Bone Cancer 9.3.1.7. Others 9.3.2. Cardiovascular and Neurological Indications 9.4. North America Market Size and Forecast, by Imaging Modality 9.4.1. Mammography 9.4.2. MRI 9.4.3. Ultrasound Imaging 9.4.4. Tomosynthesis 9.4.5. CT 9.4.6. Others 9.5. North America Market Forecast, by Country 9.5.1. U.S. 9.5.2. Canada 9.6. North America Market Attractiveness Analysis 9.6.1. By Application 9.6.2. By Imaging Modality 9.6.3. By Country 10. Europe Market Analysis 10.1. Europe Market Key Findings 10.2. Europe Market Overview 10.3. Europe Market Size and Forecast, by Application 10.3.1. Oncology 10.3.1.1. Breast Cancer 10.3.1.2. Lung Cancer 10.3.1.3. Colorectal Cancer 10.3.1.4. Prostate Cancer 10.3.1.5. Liver Cancer 10.3.1.6. Bone Cancer 10.3.1.7. Others 10.3.2. Cardiovascular and Neurological Indications 10.4. Europe Market Size and Forecast, by Imaging Modality 10.4.1. Mammography 10.4.2. MRI 10.4.3. Ultrasound Imaging 10.4.4. Tomosynthesis 10.4.5. CT 10.4.6. Others 10.5. Europe Market Forecast, by Country 10.5.1. Germany 10.5.2. U.K. 10.5.3. France 10.5.4. Spain 10.5.5. Italy 10.5.6. Rest of Europe 10.6. Europe Market Attractiveness Analysis 10.6.1. By Application 10.6.2. By Imaging Modality 10.6.3. By Country 11. Asia Pacific Market Analysis 11.1. Asia Pacific Market Key Findings 11.2. Asia Pacific Market Overview 11.3. Asia Pacific Cytometry Market Size and Forecast, by Application 11.3.1. Oncology 11.3.1.1. Breast Cancer 11.3.1.2. Lung Cancer 11.3.1.3. Colorectal Cancer 11.3.1.4. Prostate Cancer 11.3.1.5. Liver Cancer 11.3.1.6. Bone Cancer 11.3.1.7. Others 11.3.2. Cardiovascular and Neurological Indications 11.4. Asia Pacific Market Size and Forecast, by Imaging Modality 11.4.1. Mammography 11.4.2. MRI 11.4.3. Ultrasound Imaging 11.4.4. Tomosynthesis 11.4.5. CT 11.4.6. Others 11.5. Asia Pacific Market Forecast, by Country 11.5.1. China 11.5.2. India 11.5.3. Japan 11.5.4. Australia & New Zealand 11.5.5. Rest of Asia Pacific 11.6. Asia Pacific Market Attractiveness Analysis 11.6.1. By Application 11.6.2. By Imaging Modality 11.6.3. By Country 12. Latin America Market Analysis 12.1. Latin America Market Key Findings 12.2. Latin America Market Overview 12.3. Latin America Cytometry Market Size and Forecast, by Application 12.3.1. Oncology 12.3.1.1. Breast Cancer 12.3.1.2. Lung Cancer 12.3.1.3. Colorectal Cancer 12.3.1.4. Prostate Cancer 12.3.1.5. Liver Cancer 12.3.1.6. Bone Cancer 12.3.1.7. Others 12.3.2. Cardiovascular and Neurological Indications 12.4. Latin America Market Size and Forecast, by Imaging Modality 12.4.1. Mammography 12.4.2. MRI 12.4.3. Ultrasound Imaging 12.4.4. Tomosynthesis 12.4.5. CT 12.4.6. Others 12.5. Latin America Market Forecast, by Country 12.5.1. Brazil 12.5.2. Mexico 12.5.3. Rest of Latin America 12.6. Latin America Market Attractiveness Analysis 12.6.1. By Application 12.6.2. By Imaging Modality 12.6.3. By Country 13. Middle East & Africa Market Analysis 13.1. Middle East & Africa Market Key Findings 13.2. Middle East & Africa Market Overview 13.3. Middle East & Africa Cytometry Market Size and Forecast, by Application 13.3.1. Oncology 13.3.1.1. Breast Cancer 13.3.1.2. Lung Cancer 13.3.1.3. Colorectal Cancer 13.3.1.4. Prostate Cancer 13.3.1.5. Liver Cancer 13.3.1.6. Bone Cancer 13.3.1.7. Others 13.3.2. Cardiovascular and Neurological Indications 13.4. Middle East & Africa Market Size and Forecast, by Imaging Modality 13.4.1. Mammography 13.4.2. MRI 13.4.3. Ultrasound Imaging 13.4.4. Tomosynthesis 13.4.5. CT 13.4.6. Others 13.5. Middle East Market Forecast, by Country 13.5.1. South Africa 13.5.2. Saudi Arabia 13.5.3. U.A.E. 13.5.4. Rest of Middle East & Africa 13.6. Middle East Market Attractiveness Analysis 13.6.1. By Application 13.6.2. By Imaging Modality 13.6.3. By Country 14. Competition Landscape 14.1. Global Market Share Analysis, by Company (2018) 14.2. Company Profiles 14.2.1. Agfa-Gevaert N.V. 14.2.1.1. Overview (HQ, Employee Strength, Business Segments) 14.2.1.2. Financials 14.2.1.3. Recent Developments 14.2.1.4. Strategy 14.2.2. Fujifilm Holdings Corporation 14.2.2.1. Overview (HQ, Employee Strength, Business Segments) 14.2.2.2. Financials 14.2.2.3. Recent Developments 14.2.2.4. Strategy 14.2.3. Hologic, Inc. 14.2.3.1. Overview (HQ, Employee Strength, Business Segments) 14.2.3.2. Financials 14.2.3.3. Recent Developments 14.2.3.4. Strategy 14.2.4. iCAD, Inc. 14.2.4.1. Overview (HQ, Employee Strength, Business Segments) 14.2.4.2. Financials 14.2.4.3. Recent Developments 14.2.4.4. Strategy 14.2.5. Koninklijke Philips N.V. 14.2.5.1. Overview (HQ, Employee Strength, Business Segments) 14.2.5.2. Financials 14.2.5.3. Recent Developments 14.2.5.4. Strategy 14.2.6. Siemens Healthineers 14.2.6.1. Overview (HQ, Employee Strength, Business Segments) 14.2.6.2. Financials 14.2.6.3. Recent Developments 14.2.6.4. Strategy 14.2.7. Toshiba Medical Systems Corporation 14.2.7.1. Overview (HQ, Employee Strength, Business Segments) 14.2.7.2. Financials 14.2.7.3. Recent Developments 14.2.7.4. Strategy 14.2.8. GE Healthcare 14.2.8.1. Overview (HQ, Employee Strength, Business Segments) 14.2.8.2. Financials 14.2.8.3. Recent Developments 14.2.8.4. Strategy 14.2.9. Samsung Medison Co. Ltd. 14.2.9.1. Overview (HQ, Employee Strength, Business Segments) 14.2.9.2. Financials 14.2.9.3. Recent Developments 14.2.9.4. Strategy 14.2.10. Hitachi Medical Corporation (Hitachi, Ltd.) 14.2.10.1. Overview (HQ, Employee Strength, Business Segments) 14.2.10.2. Financials 14.2.10.3. Recent Developments 14.2.10.4. Strategy 14.2.11. Invivo Corporation 14.2.11.1. Overview (HQ, Employee Strength, Business Segments) 14.2.11.2. Financials 14.2.11.3. Recent Developments 14.2.11.4. Strategy 14.2.12. McKesson Corporation 14.2.12.1. Overview (HQ, Employee Strength, Business Segments) 14.2.12.2. Financials 14.2.12.3. Recent Developments 14.2.12.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 2: Global Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 3: Global Market Size (US$ Mn) Analysis, by Oncology, 2018–2022
Table 4: Global Market Size (US$ Mn) Forecast, by Oncology, 2023–2033
Table 5: Global Market Size (US$ Mn) Analysis, by Cardiovascular and Neurological Indications, 2018–2022
Table 6: Global Market Size (US$ Mn) Forecast, by Cardiovascular and Neurological Indications, 2023–2033
Table 7: Global Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 8: Global Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 9: Global Market Size (US$ Mn) Analysis, by Mammography, 2018–2022
Table 10: Global Market Size (US$ Mn) Forecast, by Mammography, 2023–2033
Table 11: Global Market Size (US$ Mn) Analysis, by MRI, 2018–2022
Table 12: Global Market Size (US$ Mn) Forecast, by MRI, 2023–2033
Table 13: Global Market Size (US$ Mn) Analysis, by Ultrasound Imaging, 2018–2022
Table 14: Global Market Size (US$ Mn) Forecast, by Ultrasound Imaging, 2023–2033
Table 15: Global Market Size (US$ Mn) Analysis, by Tomosynthesis, 2018–2022
Table 16: Global Market Size (US$ Mn) Forecast, by Tomosynthesis, 2023–2033
Table 17: Global Market Size (US$ Mn) Analysis, by CT, 2018–2022
Table 18: Global Market Size (US$ Mn) Forecast, by CT, 2023–2033
Table 19: Global Market Size (US$ Mn) Analysis, by Others, 2018–2022
Table 20: Global Market Size (US$ Mn) Forecast, by Others, 2023–2033
Table 21: Global Market Size (US$ Mn) Analysis, by Region, 2018–2022
Table 22: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 23: North America Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 24: North America Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 25: North America Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 26: North America Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 27: North America Market Size (US$ Mn) Analysis, by Country, 2018–2022
Table 28: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 29: Europe Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 30: Europe Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 31: Europe Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 32: Europe Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 33: Europe Market Size (US$ Mn) Analysis, by Country, 2018–2022
Table 34: Europe Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 35: Asia Pacific Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 36: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 37: Asia Pacific Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 38: Asia Pacific Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 39: Asia Pacific Market Size (US$ Mn) Analysis, by Country, 2018–2022
Table 40: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 41: Latin America Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 42: Latin America Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 43: Latin America Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 44: Latin America Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 45: Latin America Market Size (US$ Mn) Analysis, by Country, 2018–2022
Table 46: Latin America Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 47: MEA Market Size (US$ Mn) Analysis, by Application, 2018–2022
Table 48: MEA Market Size (US$ Mn) Forecast, by Application, 2023–2033
Table 49: MEA Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022
Table 50: MEA Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033
Table 51: MEA Market Size (US$ Mn) Analysis, by Country, 2018–2022
Table 52: MEA Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 53: U.S. Market Size (US$ Mn), 2023-2033
Table 54: Canada Market Size (US$ Mn), 2023-2033
Table 55: Brazil Market Size (US$ Mn), 2023-2033
Table 56: Mexico Market Size (US$ Mn), 2023-2033
Table 57: Argentina Market Size (US$ Mn), 2023-2033
Table 58: Germany Market Size (US$ Mn), 2023-2033
Table 59: France Market Size (US$ Mn), 2023-2033
Table 60: Italy Market Size (US$ Mn), 2023-2033
Table 61: Spain Market Size (US$ Mn), 2023-2033
Table 62: U.K. Market Size (US$ Mn), 2023-2033
Table 63: Benelux Market Size (US$ Mn), 2023-2033
Table 64: Russia Market Size (US$ Mn), 2023-2033
Table 65: China Market Size (US$ Mn), 2023-2033
Table 66: Japan Market Size (US$ Mn), 2023-2033
Table 67: South Korea Market Size (US$ Mn), 2023-2033
Table 68: India Market Size (US$ Mn), 2023-2033
Table 69: Thailand Market Size (US$ Mn), 2023-2033
Table 70: Indonesia Market Size (US$ Mn), 2023-2033
Table 71: Malaysia Market Size (US$ Mn), 2023-2033
Table 72: Australia & New Zealand Market Size (US$ Mn), 2023-2033
Table 73: GCC Countries Market Size (US$ Mn), 2023-2033
Table 74: Egypt Market Size (US$ Mn), 2023-2033
Table 75: South Africa Market Size (US$ Mn), 2023-2033
Table 76: Turkey Market Size (US$ Mn), 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Snapshot
Figure 02: Global Market Size (US$ Mn) and Distribution by Geography, 2023 and 2033
Figure 03: Global Market Size (US$ Mn) Forecast, 2023–2033
Figure 04: Global Market - Revenue Share by Application, 2018
Figure 05: Global Market - Revenue Share by Imaging Modality, 2018
Figure 07: Market Share Analysis By Imaging Modality (2018)
Figure 06: Market Share Analysis By Application (2018)
Figure 08: Market Share Analysis By Region (2018)
Figure 09: Global Market Value Share Analysis, by Application, 2023 and 2033
Figure 10: Global Market Attractiveness Analysis, by Application, 2023–2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2023–2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiovascular and Neurological Indications, 2023–2033
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2023–2033
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2023–2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2023–2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2023–2033
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liver Cancer, 2023–2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Cancer, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 20: Global Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 21: Global Market Attractiveness Analysis, by Imaging Modality, 2023–2033
Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mammography, 2023–2033
Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by MRI, 2023–2033
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ultrasound Imaging, 2023–2033
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tomosynthesis, 2023–2033
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CT, 2023–2033
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 28: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 29: Global Market Attractiveness Analysis, by Region, 2023–2033
Figure 30: North America Computer Aided Detection Market Size (US$ Mn) Forecast, 2023–2033
Figure 31: North America Market Value Share Analysis, by Application, 2023 and 2033
Figure 32: North America Market Attractiveness Analysis, by Application, 2023-2033
Figure 33: North America Computer Aided Detection Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 34: North America Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality, 2023-2033
Figure 35: North America Market Value Share Analysis, by Country, 2023 and 2033
Figure 36: North America Market Attractiveness Analysis, by Country, 2023-2033
Figure 37: Europe Computer Aided Detection Market Size (US$ Mn) Forecast, 2023–2033
Figure 38: Europe Market Value Share Analysis, by Application, 2023 and 2033
Figure 39: Europe Market Attractiveness Analysis, by Application, 2023–2033
Figure 40: Europe Computer Aided Detection Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 41: Europe Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality, 2023–2033
Figure 42: Europe Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 44: Asia Pacific Market Size (US$ Mn) Forecast, 2023–2033
Figure 45: Asia Pacific Market Value Share Analysis, by Application, 2023 and 2033
Figure 46: Asia Pacific Market Attractiveness Analysis, by Application, 2023–2033
Figure 47: Asia Pacific Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 48: Asia Pacific Market Attractiveness Analysis, by Imaging Modality, 2023–2033
Figure 49: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 50: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 51: Latin America Market Size (US$ Mn) Forecast, 2023–2033
Figure 52: Latin America Market Value Share Analysis, by Application, 2023 and 2033
Figure 53: Latin America Market Attractiveness Analysis, by Application, 2023–2033
Figure 54: Latin America Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 55: Latin America Market Attractiveness Analysis, by Imaging Modality, 2023–2033
Figure 56: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 57: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 58: Middle East & Africa Market Size (US$ Mn) Forecast, 2023–2033
Figure 59: Middle East & Africa Market Value Share Analysis, by Application, 2023 and 2033
Figure 60: Middle East & Africa Market Attractiveness Analysis, by Application, 2023–2033
Figure 61: Middle East & Africa Market Value Share Analysis, by Imaging Modality, 2023 and 2033
Figure 62: Middle East & Africa Market Attractiveness Analysis, by Imaging Modality, 2023–2033
Figure 63: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 65: Global Market Share, by Company, 2018
Figure 66: Agfa-Gevaert N.V., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018
Figure 67: Agfa-Gevaert N.V., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 68: Agfa-Gevaert N.V., Breakdown of Net Sales (%), by Region, 2018
Figure 69: Fujifilm Holdings Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018
Figure 70: Fujifilm Holdings Corporation, Breakdown of Net Sales (%), by Region, 2018
Figure 71: Fujifilm Holdings Corporation, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 72: Hologic, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018
Figure 73: Hologic, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 74: Hologic, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 75: iCAD, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 76: iCAD, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 77: iCAD, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 78: Koninklijke Philips N.V., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2022
Figure 79: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 80: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Region, 2017
Figure 81: Siemens Healthineers, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022
Figure 82: Siemens Healthineers, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 83: Siemens Healthineers, Breakdown of Net Sales (%), by Region, 2018
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated CAGR for the computer aided detection market?
Adoption of computer aided detection systems is estimated to increase at a CAGR of 10% through 2033.
What is the anticipated value of the computer aided detection market by 2033-end?
Sales of computer aided detection devices are expected to reach a market valuation of US$ 3.9 billion by 2033.
Which key factors are expected to drive the demand for computer aided detection systems?
Rapidly growing geriatric population and rising prevalence of chronic diseases are driving market growth.
Which region accounts for a prominent share of the global market?
North America accounts for around 40% share of the global computer aided detection market.
Who are the top computer aided detection device producers?
Hologic Inc., GE Healthcare, and EDDA Technology, Inc. are key computer aided detection tool providers.
Computer Aided Detection Market